Shandong Zhonghai Pharmaceutical CO. LTD

China

Back to Profile

1-8 of 8 for Shandong Zhonghai Pharmaceutical CO. LTD Sort by
Query
Aggregations
Jurisdiction
        United States 6
        World 2
IPC Class
A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra 7
A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus 6
A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella 6
A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof 6
A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid 5
See more
Found results for  patents

1.

Medicament for use in treating cardiovascular and cerebrovascular diseases

      
Application Number 16073867
Grant Number 10772932
Status In Force
Filing Date 2017-01-20
First Publication Date 2019-02-07
Grant Date 2020-09-15
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO. LTD (China)
Inventor
  • Xu, Baozhen
  • Cheng, Qian
  • Cheng, Long

Abstract

A medicament for use in treating cardiovascular and cerebrovascular diseases, the medicament includes a marine algal glycoprotein.

IPC Classes  ?

  • A61K 36/02 - Algae
  • A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
  • A61P 9/00 - Drugs for disorders of the cardiovascular system
  • A61P 3/06 - Antihyperlipidemics
  • A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
  • A61P 9/12 - Antihypertensives
  • A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • A61K 36/315 - Isatis, e.g. Dyer's woad
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
  • A61K 31/4025 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus
  • A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra
  • A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
  • A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
  • A61K 36/748 - Oldenlandia or Hedyotis

2.

Medicament for treating uremia and proteinuria

      
Application Number 16073830
Grant Number 10993976
Status In Force
Filing Date 2017-01-20
First Publication Date 2019-02-07
Grant Date 2021-05-04
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO. LTD (China)
Inventor
  • Cheng, Qian
  • Xu, Baozhen
  • Cheng, Long

Abstract

A medicament for use in treating uremia and proteinuria, the medicament being a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

IPC Classes  ?

  • A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • A61K 36/02 - Algae
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61K 36/315 - Isatis, e.g. Dyer's woad
  • A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
  • A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
  • A61K 38/00 - Medicinal preparations containing peptides
  • A61K 36/505 - Corydalis
  • A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
  • A61P 13/02 - Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
  • A61K 31/404 - Indoles, e.g. pindolol
  • A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus
  • A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra

3.

Medicament for use in treating diabetes

      
Application Number 16073848
Grant Number 10993955
Status In Force
Filing Date 2017-01-20
First Publication Date 2019-02-07
Grant Date 2021-05-04
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO. LTD (China)
Inventor
  • Xu, Baozhen
  • Cheng, Qian
  • Cheng, Long

Abstract

A medicament for treating diabetes and complications thereof, the medicament being a glycoprotein, or a mixture of a polysaccharide and a protein, or a polypeptide, or a protein.

IPC Classes  ?

  • A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61K 36/315 - Isatis, e.g. Dyer's woad
  • A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus
  • A61K 36/488 - Pueraria (kudzu)
  • A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra
  • A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
  • A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
  • A61K 31/404 - Indoles, e.g. pindolol
  • A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
  • A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
  • A61K 36/9064 - Amomum, e.g. round cardamom

4.

Medicament for use in treating fatty liver, hepatitis and cirrhosis

      
Application Number 16073860
Grant Number 11000569
Status In Force
Filing Date 2017-01-20
First Publication Date 2019-02-07
Grant Date 2021-05-11
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO. LTD (China)
Inventor
  • Cheng, Qian
  • Xu, Baozhen
  • Cheng, Long

Abstract

A medicament for use in treating fatty liver, hepatitis and cirrhosis, the medicament includes a marine algal glycoprotein.

IPC Classes  ?

  • A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
  • A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
  • A61K 36/752 - Citrus, e.g. lime, orange or lemon
  • A61K 36/315 - Isatis, e.g. Dyer's woad
  • A61K 36/02 - Algae
  • A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus
  • A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra
  • A61K 36/896 - Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
  • A61K 31/4025 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim

5.

Medicament used for treating hypertension

      
Application Number 16073876
Grant Number 11364279
Status In Force
Filing Date 2017-01-20
First Publication Date 2019-02-07
Grant Date 2022-06-21
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO. LTD (China)
Inventor
  • Cheng, Long
  • Xu, Baozhen
  • Cheng, Qian

Abstract

A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

IPC Classes  ?

  • A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • A61K 31/4025 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
  • A61K 35/62 - LeechesWorms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
  • A61K 36/02 - Algae
  • A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus
  • A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra
  • A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
  • A61K 36/25 - Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
  • A61K 36/284 - Atractylodes
  • A61K 31/7012 - Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
  • A61P 9/12 - Antihypertensives
  • A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters

6.

Medicament for treating pulmonary tuberculosis

      
Application Number 16073887
Grant Number 10772933
Status In Force
Filing Date 2017-01-20
First Publication Date 2019-02-07
Grant Date 2020-09-15
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO. LTD (China)
Inventor
  • Xu, Baozhen
  • Cheng, Qian
  • Cheng, Long

Abstract

A medicament for use in treating tuberculosis, the medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

IPC Classes  ?

  • A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
  • A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra
  • A61K 36/05 - Chlorophycota or chlorophyta (green algae), e.g. Chlorella
  • A61K 36/315 - Isatis, e.g. Dyer's woad
  • A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
  • A61K 36/428 - Trichosanthes
  • A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus
  • A61P 31/06 - Antibacterial agents for tuberculosis
  • A61K 31/351 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
  • A61K 36/195 - Strobilanthes
  • A61K 36/8945 - Dioscorea, e.g. yam, Chinese yam or water yam

7.

MEDICAMENT FOR USE IN TREATING TUBERCULOSIS

      
Application Number CN2017071822
Publication Number 2017/129052
Status In Force
Filing Date 2017-01-20
Publication Date 2017-08-03
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO., LTD (China)
Inventor
  • Xu, Baozhen
  • Cheng, Qian
  • Cheng, Long

Abstract

Provided in the present invention is a medicament for use in treating tuberculosis, the medicament being a glycoprotein, or a mixture of a polysaccharide and a protein, or a polypeptide, or a protein.

IPC Classes  ?

  • A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
  • A61K 38/08 - Peptides having 5 to 11 amino acids
  • A61K 31/175 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine having the group , N—C(O)—N=N— or , e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazonesThioanalogues thereof
  • A61K 36/04 - Rhodophycota or rhodophyta (red algae), e.g. Porphyra
  • A61P 31/06 - Antibacterial agents for tuberculosis
  • A61P 11/00 - Drugs for disorders of the respiratory system

8.

MEDICINE USED FOR TREATING INFLUENZA, UPPER RESPIRATORY TRACT INFECTION, VIRAL PNEUMONIA

      
Application Number CN2017071874
Publication Number 2017/129060
Status In Force
Filing Date 2017-01-20
Publication Date 2017-08-03
Owner SHANDONG ZHONGHAI PHARMACEUTICAL CO., LTD (China)
Inventor
  • Xu, Baozhen
  • Cheng, Long
  • Cheng, Qian

Abstract

Provided in the present invention is a medicine used for treating influenza, upper respiratory tract infection, and viral pneumonia, said medicine being a glycoprotein or polysaccharide and protein mixture or a polypeptide or a protein.

IPC Classes  ?

  • A61K 38/02 - Peptides of undefined number of amino acidsDerivatives thereof
  • A61K 38/08 - Peptides having 5 to 11 amino acids
  • A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses
  • A61P 31/12 - Antivirals
  • A61P 11/00 - Drugs for disorders of the respiratory system
  • A61P 31/06 - Antibacterial agents for tuberculosis